We would like you to consider our paper entitled "The Saccharomyces cerevisiae quinone oxidoreductase Lot6p: inhibition, stability and cooperativity" for publication in FEMS Yeast Research.
Many species contain relatively non-specific quinone oxidoreductases. The best characterised of these is the human NAD(P)H quinone oxidoreductase 1 (NQO1, DTdiaphorase, EC 1.6.5.2). This enzyme has attracted considerable interest because of its role in vitamin K metabolism, its potential as an anti-cancer drug target and its ability to stabilise the tumour suppressor protein p53 (Anwar et al., 2003; Gong et al., 2007; Nolan et al., 2007; Gong et al., 2008; Dinkova-Kostova & Talalay, 2010; Tie et al., 2011) . NQO1 is a dimeric enzyme with an FAD cofactor tightly bound to both subunits (Li et al., 1995) . This enzyme is a target for the anticoagulant drug dicoumarol (Hosoda et al., 1974; Rase et al., 1976) . In humans, there is a second, structurally similar enzyme, NQO2 (EC 1.10.99.2) (Long & Jaiswal, 2000; Vella et al., 2005) . The functions and substrates of NQO2 are currently less clear, although it is known that this enzyme is inhibited by resveratrol (Buryanovskyy et al., 2004) .
Bacteria have a range of quinone oxidoreductases including the NQO1-like MdaB, the tetrameric oxidoreductase WrbA, the azoreductase AzoR and the so-called nitroreductases (e.g. NemA, NfsA, NfsB, YdjA) (Zenno et al., 1996a; Zenno et al., 1996b; Kobori et al., 2001; Lovering et al., 2001; Adams & Jia, 2006; Ito et al., 2006; Patridge & Ferry, 2006; Andrade et al., 2007; Carey et al., 2007; Choi et al., 2008; Hong et al., 2008; Prosser et al., 2010; Mercier et al., 2013) . The name of the last group arises due to their ability to catalyse the reduction of a range of nitrogenous compounds, for example nitrobenzene, trinitrotoluene, chloramphenicol, and the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) (Anlezark et al., 1992; Caballero et al., 2005; Smith et al., 2007; Yanto et al., 2010) . In the budding yeast,
Saccharomyces cerevisiae, there is one such enzyme, Lot6p (EC 1.5.1.39; Ylr011wp) (Zhang et al., 2001) . This enzyme resembles the bacterial azo-and nitroreductases in (Liger et al., 2004; Sollner et al., 2007) .
All quinone oxidoreductases characterised to date have a substituted enzyme ("pingpong") mechanism in which a reducing agent (usually NADH or NADPH), transfers a hydride to the FAD or FMN cofactor. The oxidised NAD(P) + then leaves the active site, enabling the second substrate to enter and be reduced by the cofactor (Hosoda et al., 1974; Sollner et al., 2007; Sollner et al., 2009b) . The range of possible substrates is broad. In addition to a wide range of quinones and quinone derivatives, human NQO1 has been shown in vitro to catalyse the reduction of aromatic nitrogen compounds and iron(III) ions (Sarlauskas et al., 1997; Anusevicius et al., 2002; Miseviciene et al., 2006; Newsome et al., 2007; Onyenwoke & Wiegel, 2007) .
Lot6p was first identified as the protein encoded by one of a diverse group of low temperature (LOT) sensitive genes. This group also included fructose 1,6bisphosphate aldolase (FBA1 or LOT1), a ribosomal subunit (RPL2B or LOT2), a nucleolar RNA processing enzyme (NOP1 or LOT3), a gene of unknown function (LOT5) (Zhang et al., 2001) . The structure of Lot6p has been solved and revealed a typical flavodoxin fold (Liger et al., 2004) . The enzyme has been shown to catalyse the NADPH-dependent reduction of a range of biologically relevant quinones including 1,4-benzoquinone, 1,4-naphthoquinone and duroquinone (Sollner et al., 2007) in addition to ferricyanide, azo dyes and nitrocompounds (Liger et al., 2004) .
The activity with quinones is important in minimising toxicity by these compounds: a strain deleted for LOT6 is less viable than the wild-type in the presence of micromolar 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Yap4p and protects Yap4p from proteosomal degradation (Sollner et al., 2009c) .
Lot6p also induces apoptosis: strains deleted for LOT6 are less likely to undergo apoptosis when challenged with hydrogen peroxide (Sollner et al., 2009a) .
In contrast to mammalian NQO1 and NQO2, relatively little data has been collected on the biochemical properties of Lot6p. Here we extend previous enzymological and biochemical work by describing Lot6p's kinetics, inhibition and stability to thermal denaturation. We describe, for the first time in detail, the enzyme's kinetics with NADH as a reducing agent and quantify its inhibition by the organic compounds curcumin, resveratrol and nicotinamide. These compounds were selected for their ability to bind to the active sites of NQO1, NQO2 and bacterial nitroreductases respectively (Buryanovskyy et al., 2004; Tsvetkov et al., 2005; LinWu et al., 2012) .
Vanadate ions were also studied as a phosphate analogue. In some cases, but not all, these compounds acted with negative cooperativity. Models of Lot6p in complex with these compounds were built in order to help explain their different behaviour.
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Materials and Methods

Expression and purification of wild type and mutant Lot6p
Another colony was picked and grown overnight shaking at 37 °C in 5 ml of LB broth supplemented with 100 µgml -1 ampicillin. The culture was diluted into 1 l of the same medium and grown at 37 °C for 4 h until mid-log phase was reached (A 600~0 .6). The culture was induced by the addition of IPTG to a final concentration of 1.7 mM, and grown for a further 4 h at 37 °C. The cells were then collected by centrifugation at coding sequence (GATC Biotech). The mutant enzyme was expressed and purified using the same procedures as for the wild type.
Protein concentrations were determined using the method of Bradford (Bradford, 1976) using BSA as a standard and the purified Lot6p stored in 20 µl and 50 µl aliquots frozen at -80 °C.
Enzyme kinetic analysis of Lot6p
Lot6p activity was measured at 30 ºC in 50 mM HEPES, pH 7.3 using either NADH or NADPH as the electron donor and DCPIP as the electron acceptor. Reaction rates were determined by measuring the rate of decrease in absorbance at 600 nm resulting from the reduction of DCPIP (70 µM). The enzyme concentration ranged from 1.25 nM to 10 nM. Absorbance readings were taken every 5 s and all reactions were carried out in triplicate in 96-well plates. A calibration curve of A 600 against [DCPIP] was constructed in triplicate in a 96-well plate to determine a value for εL in the Beer Lambert Law, A=εLc were A is absorbance, c is concentration, ε is the molar extinction coefficient of DCPIP and L is the pathlength. The resulting equation of the where k cat,app is the apparent turnover number (equal to the apparent maximal rate, V max,app , divided by the enzyme concentration), K m,app is the apparent Michaelis-
Menten constant, [E] is the concentration of Lot6p dimer and [S] is the concentration
of either NADH or NADPH.
Inhibition kinetics
The effect of potential inhibitors (resveratrol, nicotinamide, curcumin and vanadate ions) on the enzyme-catalyzed rate measured at three concentrations of NADH and three concentrations of NADPH with a constant DCPIP concentration (70 µM). Dilution series of resveratrol and curcumin were prepared such that the final volume of DMSO in each reaction mixture was 0.5% (v/v). Nicotinamide and sodium metavanadate were dissolved in 50 mM HEPES pH 7.3. Dixon plots (Dixon, 1953) for each concentration of electron donor were constructed and the apparent inhibition constant, K i,app was obtained by determining the inhibitor concentration at which the lines corresponding to each NAD(P)H concentration intercepted.
A concentration range for each inhibitor was chosen based on these K i,app values and an inhibitor titration was carried out using a concentration approximately equal to K m,app for NADH (250 µM) or NADPH (100 µM) and DCPIP (70 µM). Linearized
Hill plots(-log 10 (v/(v 0 -v)) against -log 10 [inhibitor], where v is the rate of the inhibited reaction and v 0 is the rate in the absence of inhibitor) were constructed for each inhibitor; the gradient of these is the Hill coefficient, h (Hill, 1910) .
Crosslinking and limited proteolysis
Increasing concentrations of the chemical cross-linkers bissulfosuccinimidylsuberate
were added to a constant concentration of Lot6p (35 µM dimer) which had been preincubated at 30 °C for 5 min. The reaction was allowed to proceed for 30 min after which time it was stopped by the addition of an equal volume of SDS loading buffer (120 mM TrisHCl pH 6.
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where ∆T m max is the maximum, limiting change in melting temperature (T m ), and K D,app is the apparent dissociation constant for ligand and Lot6p.
Molecular modelling
Models of Lot6p with ligands bound were based on the experimentally determined 
Results
Recombinant expression and dimerisation of Lot6p
Lot6p can be expressed in, and purified from, E. coli with a typical yield of approximately 12 mg purified protein per litre of initial culture (Fig 1a) . Crosslinking with both EDC and BS 3 showed that Lot6p is a dimer (Fig. 1b ) and the amount of crosslinking observed was unchanged in the presence of resveratrol, nicotinamide and curcumin; however, vanadate ions reduced the amount of crosslinked product observed ( Fig. 1c ). . 2) .
Quinone oxidoreductase inhibitors stabilise Lot6p
The melting temperature of Lot6p, as judged by TSF, was 56.9±0.4 °C in HEPES buffer. Lot6p is slightly stabilised by phosphate ions; the T m increased to 58.9±0.4 °C in 50 mM phosphate buffer ( Supplementary Fig. S1 ). Resveratrol and nicotinamide stabilised Lot6p in a saturatable, concentration-dependent manner. The apparent dissociation constants with resveratrol and nicotinamide were 0.091±0.026 mM and 24.5±3.4 mM respectively ( Fig. 3 ).
Inhibition of Lot6p is negatively cooperative with some compounds
The oxidoreductase activity of Lot6p was inhibited by curcumin, resveratrol, nicotinamide and vanadate. Dixon plots for all four compounds with NADH and NADPH as the reducing agent intersected as expected for competitive inhibition (Dixon, 1953) . For each inhibitor except vanadate, the K i,app values obtained with NADH and NADPH were similar ( Fig. 4 ; Table 1 ). Of the organic compounds, nicotinamide has the highest K i,app followed by curcumin and resveratrol which was the most effective inhibitor tested ( Fig. 4; Table 1 ). Lot6p exhibits negative cooperativity with the inhibitors resveratrol, curcumin, and vanadate when inhibiting 5 ; Table 2 ).
Molecular modelling of Lot6p and inhibitors
Nicotinamide, resveratrol and curcumin were all predicted to bind in the enzyme's active site, lying across the partly exposed surface of the isoalloxazine ring of the FMN cofactor, consistent with their role as competitive inhibitors (Fig. 6, left column). The two larger molecules, resveratrol and curcumin, extend beyond the active site into a cleft between the two polypeptide chains of the Lot6p dimer.
Interestingly, resveratrol is predicted to make contact with an α-helix (residues Ser-130 to Leu-143) which links the two active sites of the dimeric enzyme ( Fig. 6, right column). Curcumin contacts the equivalent α-helix in the other subunit. The smaller molecule, nicotinamide, does not contact this helix. Vanadate could, potentially, bind at a variety of sites including those for the three phosphate groups in NADPH. In the absence of any structures of quinone oxidoreductases bound to vanadate, no modelling was attempted with this inhibitor.
Mutation of a key residue reduces the degree of negative cooperativity
From the molecular models, we noticed that resveratrol contacts the α-helix which links the two active sites close to a glycine residue (Gly-142). Given the role of glycine in protein flexibility and the importance of such mobility in phenomena such as cooperativity (Goodey & Benkovic, 2008) , we reasoned that altering this residue might affect cooperativity towards the inhibitors. Alteration of Gly-142 to serine results in an active enzyme, which is dimeric, has Michaelis-Menten kinetics with NADH and is inhibited by resveratrol and vanadate ( Supplementary Fig S2, S3, S4 ; Table 3 ). The apparent inhibition constants for these compounds with respect to NADH were increased approximately two-fold (Table 3 ). The enzyme is slightly more stable towards thermal denaturation than the wild type (T m values of 60.9±0.2 ºC and 61.5±0.6 ºC in phosphate and hepes buffer respectively; Supplementary Fig.   S5 ). This is consistent with a less flexible overall structure. Resveratrol and nicotinamide both stabilise the G142S variant protein, with apparent dissociation constants similar to those of the wild-type (Table 3 , Supplementary Fig. S6 ).
However, the degree of negative cooperativity towards resveratrol and vanadate was less than that seen with the wild type; for both compounds, the Hill coefficient rose towards one (Table 3 , Fig. 7 ).
Discussion
Previous studies of Lot6p have concentrated on its activity with NADPH as an electron donor (Sollner et al., 2007) . Here, it is demonstrated that NADH functions as an electron donor, albeit with a higher apparent Michaelis constant and lower turnover number. Lot6p's location in the cytoplasm (Sollner et al., 2007) means that it is more likely to encounter NADPH since the NADPH:NADH concentration ratio in the cytoplasm is generally greater than one (Jacbonson & Kaplan, 1957) . However, it has been demonstrated that, in S. cerevisiae, environmental changes (e.g. altered nutrient sources) can alter this ratio (Satrustegui et al., 1983; Nissen et al., 2001; Celton et al., 2012; Ask et al., 2013) . Therefore, both reducing agents are likely to be important in vivo. Despite the dimeric nature of the enzyme, and the involvement of residues from both polypeptides in the two active sites, no cooperativity with respect to NADH or NADPH was detected in our experiments. inhibitors has previously been observed with mammalian NQO1 when inhibited with dicoumarol -although the molecular mechanism and physiological significance remains obscure (Rase et al., 1976) . The molecular models (Fig. 6) suggest a potential mechanism for inter-active site communication and also why nicotinamide is unable to initiate this. Both resveratrol and curcumin are predicted to contact an extended α-helix at the interface between the two polypeptides of the dimer. This helix links the two active sites and so it is plausible that alterations to its conformation induced by an inhibitor binding at one active site may affect the conformation of the second active site. Nicotinamide is predicted to bind parallel to the FMN cofactor and does not make contact with this helix; therefore it would be unable to initiate information transmission between the active sites. Given that, like all models, these should be treated with some caution, we tested the hypothesis by mutating a glycine residue in this helix. The resulting protein had similar kinetic properties and stability to the wild type protein, but showed less negative cooperativity (i.e. higher value of h) towards resveratrol and vanadate. This result supports the hypothesis that this helix plays a key role in transmitting information between the active sites in Lot6p. It also confirms that the non-Michaelian kinetics observed with inhibitors arises from genuine inter-active site cooperativity and not from intra-molecular aggregation or some other artefact. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Values are the mean of the intersection points in the Dixon plot and the errors are the standard deviation of these means. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 ScholarOne Support 1-434/964-4100 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42 
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